CCR

CC chemokine receptor (CCR) antagonists block G protein-coupled receptors that guide leukocyte migration. CCR2, a receptor for monocyte chemoattractant protein 1 (MCP-1), was cloned in 1994 as two splice variants. CCR5 was identified in 1996 as a fusion cofactor for macrophage-tropic human immunodeficiency virus type 1 (HIV-1). Maraviroc, described in 2005 as a selective small-molecule CCR5 inhibitor, blocks this route of viral entry. Other CCR5 antagonists include vicriviroc malate and aplaviroc, while INCB3344 and MK-0812 target CCR2. Cenicriviroc blocks both CCR2 and CCR5, and GSK2239633A is a CCR4 antagonist for studies of T cell trafficking.

Items 26-50 of 154

  • AZ084
    Cat. No.
    A19143

    AZ084

    AZ084 is a potent, selective, allosteric and oral active CCR8 antagonist, with a Ki of 0.9 nM. Has potential to treat asthma.

    1 mg
    $75.00
    5 mg
    $165.00
    All 8 sizes
  • SB297006
    Cat. No.
    A19274

    SB297006

    SB297006 is a CCR3 antagonist, which significantly inhibits proliferation and neurosphere formation in CCL11-treated neural progenitor cells.

    2 mg
    $25.00
    5 mg
    $40.00
    All 7 sizes
  • GW 766994
    Cat. No.
    A20039

    GW 766994

    Synonyms: GW 994,GW-994; GW994

    GW 766994 is a specific and oral chemokine receptor-3 (CCR3) antagonist, which has entered clinical trial for asthma and eosinophilic bronchitis.

    5 mg
    $345.00
    10 mg
    $555.00
    All 5 sizes
  • E6130
    Cat. No.
    A20056

    E6130

    E6130 is an orally available and highly selective CX3CR1 modulator, that may be effective for treatment of inflammatory bowel disease.

    5 mg
    $415.00
    10 mg
    $715.00
    All 5 sizes
  • CCR5 antagonist 1
    Cat. No.
    A20439

    CCR5 antagonist 1

    CCR5 antagonist 1 is a CCR5 antagonist which can inhibit HIV replication extracted from WO 2004054974 A2.

    1 mg
    $680.00
    5 mg
    $980.00
    All 6 sizes
  • TAK-220
    Cat. No.
    A20618

    TAK-220

    TAK-220 is a selective and orally bioavailable CCR5 antagonist.

    1 mg
    $155.00
    5 mg
    $245.00
    All 7 sizes
  • CCR2-RA-[R]
    Cat. No.
    A20644

    CCR2-RA-[R]

    CCR2-RA-[R] is an allosteric antagonist of the C-C chemokine receptor type 2 (CCR2) with an IC50 of 103 nM.

    2 mg
    $30.00
    5 mg
    $55.00
    All 7 sizes
  • RS102895 hydrochloride
    Cat. No.
    A20918

    RS102895 hydrochloride

    Synonyms: RS 102895

    RS102895 hydrochloride is a potent CCR2 antagonist, with an IC50 of 360 nM, and shows no effect on CCR1.

    2 mg
    $35.00
    5 mg
    $55.00
    All 7 sizes
  • Vercirnon
    Cat. No.
    A21315

    Vercirnon

    Synonyms: GSK-1605786; CCX282-B; Traficet-EN

    Vercirnon (GSK-1605786) is an orally bioavailable, selective, and potent antagonist of CCR9, with an IC50 of 10 nM, used in the research of inflammatory bowel diseases.

    1 mg
    $100.00
    5 mg
    $265.00
    All 8 sizes
  • BX471 hydrochloride
    Cat. No.
    A21886

    BX471 hydrochloride

    Synonyms: ZK-811752 hydrochloride; ZK811752; TAK 659

    BX471 hydrochloride (ZK-811752 hydrochloride) is a potent, selective non-peptide CCR1 antagonist with Ki of 1 nM for human CCR1, and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.

    5 mg
    $95.00
    10 mg
    $130.00
    All 5 sizes
  • R243
    Cat. No.
    A22123

    R243

    R243 is an inhibitor of CCR8 signaling and chemotaxis.

    1 mg
    $30.00
    2 mg
    $45.00
    All 8 sizes
  • Nifeviroc
    Cat. No.
    A22478

    Nifeviroc

    Synonyms: TD-0232

    Nifeviroc is a CCR5 antagonist potentially for treatment of inflammatory responses to HIV type-1 infection

    1 mg
    $135.00
    5 mg
    $345.00
    All 6 sizes
  • CKLF1-C19
    Cat. No.
    A22999

    CKLF1-C19

    CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1). CKLF1-C19 interacts with CCR4, and inhibits chemotaxis induced by both CKLF1 and CCL17. CKLF1-C19 can suppress allergic lung inflammation via inhibiting chemotaxis mediated by CCR3 and CCR4.

    1 mg
    $30.00
    5 mg
    $95.00
    All 3 sizes
  • AZD2098
    Cat. No.
    A23971

    AZD2098

    AZD2098 is a potent and selective CCR4 inhibitor with pIC₅₀ values of 7.8–8.0 across human, rat, mouse, and dog. It is commonly used in asthma research to study CCR4-mediated inflammatory pathways.

    5 mg
    $77.00
    10 mg
    $132.00
    All 4 sizes
  • NSC177365
    Cat. No.
    A49498

    NSC177365

    Synonyms: NSC 1

    NSC177365 is a potent CcrM inhibitor that acts by competitively disrupting DNA binding. It demonstrates significant antibacterial activity, displaying IC50 values of 2.3 μM and 14.6 μM against C. crescentus and M. lincolnii, respectively. Furthermore, NSC177365 has potential applications in reversing neurodegenerative disorders and shows promise as an anticancer agent, making it a valuable tool for chemical research.

    Out of stock

    All 3 sizes
  • Cosalane
    Cat. No.
    A51266

    Cosalane

    Synonyms: NSC 658586

    Cosalane is a dual antagonist of the chemokine receptors CCR7 (IC50 = 2.43 μM) and CXCR2 (IC50 = 0.66 μM). This compound effectively inhibits HIV replication across a variety of strains, including HIV-1, HIV-2, Rauscher murine leukemia virus, as well as herpes simplex viruses HSV-1 and HSV-2, and human cytomegalovirus. Cosalane disrupts the interaction between gp120 and CD4, inhibiting signaling downstream of CCR7 in response to its ligands CCL19 and CCL21. Research applications include studies on HIV and the potential modulation of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

    1 mg
    $300.00
    5 mg
    $710.00
    All 4 sizes
  • DAPTA
    Cat. No.
    A51268

    DAPTA

    Synonyms: D-Ala-peptide T-amide; Adaptavir

    DAPTA is a synthetic peptide that acts as a selective inhibitor of the CCR5 receptor. By blocking CCR5, DAPTA interferes with viral entry into host cells, exhibiting significant anti-HIV activity. This compound is valuable for research in virology and the development of therapeutic strategies against HIV.

    1 mg
    $30.00
    5 mg
    $75.00
    All 7 sizes
  • Aplaviroc hydrochloride
    Cat. No.
    A51303

    Aplaviroc hydrochloride

    Synonyms: AK602 hydrochloride; GSK-873140 hydrochloride; GW-873140 hydrochloride

    Aplaviroc hydrochloride is a potent CCR5 antagonist targeting the CCR5 co-receptor. It demonstrates biological activity with IC50 values ranging from 0.1 to 0.4 nM against various HIV-1 strains, including HIV-1Ba-L, HIV-1JRFL, and HIV-1MOKW. This compound is valuable for research applications focused on HIV entry inhibition and the development of antiviral therapies.

    5 mg
    $310.00
    10 mg
    $505.00
    All 5 sizes
  • CCR5 antagonist 3
    Cat. No.
    A51409

    CCR5 antagonist 3

    CCR5 antagonist 3 is a potent inhibitor of the CCR5 receptor, exhibiting an IC50 of 15.90 nM. This compound demonstrates broad-spectrum anti-HIV-1 activity, making it a valuable tool for research focused on HIV-1 infection mechanisms and therapeutic development. Its specificity for CCR5 enhances its potential utility in studying chemokine receptor modulation and viral entry inhibition in various biological contexts.

    Out of stock

    All 3 sizes
  • Ancriviroc
    Cat. No.
    A51421

    Ancriviroc

    Synonyms: SCH-351125

    Ancriviroc is a small molecule CCR5 antagonist that demonstrates potent antiviral activity against various HIV-1 isolates that utilize CCR5 as an entry coreceptor, with IC50 values ranging from 0.4 to 9 nM. This compound effectively inhibits the replication of R5-utilizing HIV-1 strains in the SCID-hu Thy/Liv mice model of HIV-1 infection. Ancriviroc is a valuable tool for research focused on HIV infection and the exploration of therapeutic strategies targeting CCR5.

    1 mg
    $155.00
    5 mg
    $395.00
    All 6 sizes
  • INCB9471
    Cat. No.
    A51429

    INCB9471

    INCB9471 is a potent and selective CCR5 antagonist that serves as a critical resource for HIV-1 research. This orally active compound effectively inhibits CCR5-mediated entry of HIV-1 into host cells, demonstrating significant anti-HIV-1 activity. Its targeted mechanism of action makes INCB9471 a valuable tool for studying HIV pathogenesis and developing therapeutic strategies against HIV infection.

    1 mg
    $500.00
    5 mg
    $1,105.00
    All 5 sizes
  • Vicriviroc
    Cat. No.
    A51438

    Vicriviroc

    Synonyms: SCH 417690; SCH-D; MK-7690 free base

    Vicriviroc is a potent CCR5 antagonist with an IC50 of 10 nM. It effectively inhibits the release of MIP-1α and intracellular calcium levels induced by the ligand RANTES, with IC50 values of 0.91 nM and 16 nM, respectively. Vicriviroc is primarily utilized in research related to human immunodeficiency virus type 1 (HIV-1) infection and holds potential for cancer studies.

    25 mg
    $1,780.00
    50 mg
    $2,280.00
    All 3 sizes
  • PF-232798
    Cat. No.
    A51467

    PF-232798

    PF-232798 is an orally bioavailable antagonist of the CCR5 receptor, primarily known for its role in HIV entry into cells. By blocking CCR5, PF-232798 demonstrates efficacy in inhibiting HIV replication and offers potential applications in antiviral research. Its selective activity makes it a valuable tool for studying HIV pathogenesis and developing new therapeutic strategies against the virus.

    Out of stock

    All 3 sizes

Items 26-50 of 154

Added to your cart

View Cart Checkout

    Loading...